Clinical trial
Effectiveness of Inpatient Initiated Varenicline Tartrate for Smoking Cessation, for Smoking Related Illnesses.
NCT01141855 is registered in ClinicalTrials.gov with The Queen Elizabeth Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Inpatient Initiated Varenicline Tartrate for Smoking Cessation, for Smoking Related Illnesses.
- Lead sponsor
- The Queen Elizabeth Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- December 31, 2011
- Enrollment
- 392 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.